Stock Scorecard
Stock Summary for Neuronetics Inc (STIM) - $0.80 as of 11/20/2024 8:44:57 PM EST
Total Score
10 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for STIM
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for STIM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for STIM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for STIM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for STIM (29 out of 90)
Stock Price Rating (Max of 10) | 1 |
Historical Stock Price Rating (Max of 10) | 5 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 2 |
Book Value to Price (Max of 10) | 8 |
Analyst Buy Ratings (Max of 5) | 2 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 6 |
Price to Earnings (Max of 10) | 0 |
Latest News for for STIM
Financial Details for STIM
Company Overview |
|
---|---|
Ticker | STIM |
Company Name | Neuronetics Inc |
Country | USA |
Description | Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 1/6/2025 |
Stock Price History |
|
Last Day Price | 0.80 |
Price 4 Years Ago | 11.11 |
Last Day Price Updated | 11/20/2024 8:44:57 PM EST |
Last Day Volume | 504,787 |
Average Daily Volume | 575,450 |
52-Week High | 5.07 |
52-Week Low | 0.52 |
Last Price to 52 Week Low | 53.85% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 52.46 |
Sector PE | 40.32 |
5-Year Average PE | -4.00 |
Free Cash Flow Ratio | 1.16 |
Industry Free Cash Flow Ratio | 35.05 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 3.16 |
Total Cash Per Share | 0.69 |
Book Value Per Share Most Recent Quarter | 1.18 |
Price to Book Ratio | 2.30 |
Industry Price to Book Ratio | 5.44 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 0.33 |
Industry Price to Sales Ratio Twelve Trailing Months | 13.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 1 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 30,347,500 |
Market Capitalization | 24,278,000 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 18.76% |
Reported EPS 12 Trailing Months | -1.34 |
Reported EPS Past Year | -1.04 |
Reported EPS Prior Year | -1.07 |
Net Income Twelve Trailing Months | -36,423,000 |
Net Income Past Year | -30,189,000 |
Net Income Prior Year | -37,159,000 |
Quarterly Revenue Growth YOY | -6.60% |
5-Year Revenue Growth | 4.61% |
Operating Margin Twelve Trailing Months | -0.52 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 20,900,000 |
Total Cash Past Year | 59,677,000 |
Total Cash Prior Year | 70,300,000 |
Net Cash Position Most Recent Quarter | -25,102,000 |
Net Cash Position Past Year | 394,000 |
Long Term Debt Past Year | 59,283,000 |
Long Term Debt Prior Year | 35,954,000 |
Total Debt Most Recent Quarter | 46,002,000 |
Equity to Debt Ratio Past Year | 0.37 |
Equity to Debt Ratio Most Recent Quarter | 0.17 |
Total Stockholder Equity Past Year | 34,190,000 |
Total Stockholder Equity Prior Year | 57,060,000 |
Total Stockholder Equity Most Recent Quarter | 9,381,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -22,524,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.74 |
Free Cash Flow Past Year | -34,407,000 |
Free Cash Flow Prior Year | -34,008,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.02 |
MACD Signal | 0.03 |
20-Day Bollinger Lower Band | 0.32 |
20-Day Bollinger Middle Band | 1.20 |
20-Day Bollinger Upper Band | 2.08 |
Beta | 2.22 |
RSI | 33.22 |
50-Day SMA | 2.36 |
150-Day SMA | 2.96 |
200-Day SMA | 4.97 |
System |
|
Modified | 11/19/2024 1:31:19 PM EST |